Follow the Medline Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €45.6bn. The latest transaction was reported on 17 August 2026 (Cession). Among the most active insiders: BCP 8 Holdings Mozart Manager L.L.C.. The full history is openly available.
71
Insider Decl.
n/a
Thresholds
€147,016
1 ops.
Buy Volume
€8bn
24 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Medline Inc. Buy (bullish), based on 26 analysts. Average price target: US$44.62.
35Σ signal
Buys €147,016€8bn Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,791 of 29,062 companies
39.8
score / 100
Value
42
Quality
38
FCF yld2.7%
Earn yld2.4%
EV/EBITDA19.6x
ROE4.9%
Gross mgn26%
Net mgn4.1%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.